2.33
+0.16(+7.37%)
Currency In USD
| Previous Close | 2.17 |
| Open | 2.18 |
| Day High | 2.37 |
| Day Low | 2.18 |
| 52-Week High | 5.24 |
| 52-Week Low | 1.87 |
| Volume | 21,578 |
| Average Volume | 41,850 |
| Market Cap | 95.22M |
| PE | -1.25 |
| EPS | -1.86 |
| Moving Average 50 Days | 2.77 |
| Moving Average 200 Days | 3.47 |
| Change | 0.16 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $160.69 as of April 26, 2025 at a share price of $2.33. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $331.44 as of April 26, 2025 at a share price of $2.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
GlobeNewswire Inc.
Apr 22, 2025 8:05 PM GMT
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participat
Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice
GlobeNewswire Inc.
Apr 21, 2025 12:00 PM GMT
— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device (CIED) procedures — SILVER SPRING, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT
Elutia Confirms No Material Impact from Global Tariffs
GlobeNewswire Inc.
Apr 14, 2025 12:00 PM GMT
SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has had no material impact on it